Zobrazeno 1 - 10
of 148
pro vyhledávání: '"Honey V Reddi"'
Autor:
Gulrayz Ahmed, Yasir Abdelgadir, Amro Abdelghani, Pippa Simpson, Jody Barbeau, Donald Basel, Christy S. Barrios, Brandon A Smith, Kala F Schilter, Rupa Udani, Honey V. Reddi, Rodney E. Willoughby
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Severe COVID-19 is uncommon, restricted to 19% of the total population. In response to the first virus wave (alpha variant of SARS-CoV-2), we investigated whether a biomarker indicated severity of disease and, in particular, if va
Externí odkaz:
https://doaj.org/article/c99de854ce664f45b4195da09f7c0401
Autor:
Ryan T. Evans, Elizabeth Gillon-Zhang, Julia N. Brown, Katherine E. Knudsen, Candace King, Amanda S. Green, Ana-Luisa Silva, Justyna M. Mordaka, Rebecca N. Palmer, Alessandro Tomassini, Alejandra Collazos, Christina Xyrafaki, Iyelola Turner, Chau Ha Ho, Dilyara Nugent, Jinsy Jose, Simonetta Andreazza, Nicola D. Potts, Kristine von Bargen, Eleanor R. Gray, Magdalena Stolarek-Januszkiewicz, Aishling Cooke, Honey V. Reddi, Barnaby W. Balmforth, Robert J. Osborne
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionGenomic variant testing of tumors is a critical gateway for patients to access the full potential of personalized oncology therapeutics. Current methods such as next-generation sequencing are costly and challenging to interpret, while PCR
Externí odkaz:
https://doaj.org/article/d85ec7340182407fb115b7be0c9d6705
Autor:
Honey V. Reddi, Youri I. Pavlov
Publikováno v:
Frontiers in Genetics, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/526d457a1d884603b5638a7cdc465701
Autor:
Kala F Schilter, Sarah Dubay, Matt Stachowiak, Alysia Kaplan, Abby Stauffenger, Honey V Reddi
Publikováno v:
Biomarker Insights, Vol 18 (2023)
Precision medicine for oncology requires the evaluation of variants identified in molecular profiling of solid tumors and hematologic malignancies. This includes evaluation of pre-analytical and postanalytical quality metrics, variant interpretation,
Externí odkaz:
https://doaj.org/article/f54d41692d114fc2bf25ff75d05592fa
Autor:
Kala F. Schilter, Brandon A. Smith, Qian Nie, Kathryn Stoll, Juan C. Felix, Jason A. Jarzembowski, Honey V. Reddi
Publikováno v:
Frontiers in Genetics, Vol 14 (2023)
Next-Generation Sequencing (NGS) allows rapid analysis of multiple genes for the detection of clinically actionable variants. This study reports the analytical validation of a targeted pan cancer NGS panel CANSeqTMKids for molecular profiling of chil
Externí odkaz:
https://doaj.org/article/380c30c4125c4e12af75b4f9ff832bc0
Autor:
Christopher S. Langlo, Alana Trotter, Honey V. Reddi, Kala F. Schilter, Rebecca C. Tyler, Rupa Udani, Maureen Neitz, Joseph Carroll, Thomas B. Connor
Publikováno v:
American Journal of Ophthalmology Case Reports, Vol 25, Iss , Pp 101241- (2022)
Purpose: Many retinal disorders present with pigmentary retinopathy, most of which are progressive conditions. Here we present over nine years of follow up on a case of stable pigmentary retinopathy that is suspected to stem from a congenital rubella
Externí odkaz:
https://doaj.org/article/54ea1c402b6c4b9a831d7e9982294748
Autor:
Yue Zhao, Ziwei Pan, Sandeep Namburi, Andrew Pattison, Atara Posner, Shiva Balachander, Carolyn A. Paisie, Honey V Reddi, Jens Rueter, Anthony J Gill, Stephen Fox, Kanwal P.S. Raghav, William F Flynn, Richard W. Tothill, Sheng Li, R. Krishna Murthy Karuturi, Joshy George
Publikováno v:
EBioMedicine, Vol 61, Iss , Pp 103030- (2020)
Background: Cancer of unknown primary (CUP), representing approximately 3-5% of all malignancies, is defined as metastatic cancer where a primary site of origin cannot be found despite a standard diagnostic workup. Because knowledge of a patient's pr
Externí odkaz:
https://doaj.org/article/2e9c24dab6e948a488ab77e4c14eacf9
Autor:
Andrew N. Hesse, William Fabricius, Christian A. Thomas, Ramesh Gaindh, Robert Christman, Pavalan Selvam, Matthew Prego, Gregory Lewis, Jasmina Uvalic, Daniel Bergeron, Shelbi Burns, Bridgette Sisson, Kevin Kelly, Jens Rueter, Honey V. Reddi
Publikováno v:
Case Reports in Oncology, Vol 11, Iss 1, Pp 196-205 (2018)
Molecular profiling of urothelial cancers for therapeutic and prognostic potential has been very limited due to the absence of cancer-specific targeted therapies. We describe here 2 clinical cases with a histological diagnosis of an invasive sarcomat
Externí odkaz:
https://doaj.org/article/6d6ba0ed25394dca9933347338ee0749
Autor:
Bridgette A Sisson, Jasmina Uvalic, Kevin Kelly, Pavalan Selvam, Andrew N Hesse, Guruprasad Ananda, Harshpreet Chandok, Daniel Bergeron, Lauren Holinka, Honey V Reddi
Publikováno v:
Biomarker Insights, Vol 14 (2019)
The standard of care in oncology has been genomic profiling of tumor tissue biopsies for the treatment and management of disease, which can prove to be quite challenging in terms of cost, invasiveness of procedure, and potential risk for the patient.
Externí odkaz:
https://doaj.org/article/cbf831e651014c2fa1528cbde2edf9a2
Autor:
Ryan W Huey, Aakash Tushar Shah, Honey V Reddi, Priyadarsini Dasari, James T Topham, Hyunsoo Hwang, Nishat Dhillon, Anneleis Willett, Brandon Smaglo, Jeannelyn S Estrella, Asif Rashid, Aurelio Matamoros, Michael J Overman, Linda Choquette, Greg Omerza, Kevin Kelly, Xuemei Wang, Jonathan M Loree, Jens Rueter, Gauri R Varadhachary, Kanwal Raghav
Publikováno v:
JNCI: Journal of the National Cancer Institute.
Real-world evidence regarding the value of integrating genomic profiling (GP) in managing cancer of unknown primary (CUP) is limited. We assessed this clinical utility using a prospective trial of 158 patients with CUP (10/2016-09/2019) who underwent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90dba338af4543c046308c1877c12a54
https://doi.org/10.1093/jnci/djad095
https://doi.org/10.1093/jnci/djad095